Is "Cushing's disease of the omentum" an affliction of mouse and men?

Diabetologia

Volumn 47, Issue 5, 2004, Pages 767-769

  Walker, B R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID; HYDROCORTISONE;

CUSHING DISEASE; DIABETIC OBESITY; DYSLIPIDEMIA; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; LIVER METABOLISM; NONHUMAN; NOTE; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; OBESITY; PITUITARY ACTH HYPERSECRETION;

EID: 2942538561     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1390-y     Document Type: Note

References (27)

1. Bujalska IJ, Kumar S, Stewart PM (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349:1210-1213
2. Aldhahi W, Mun E, Goldfine AB (2004) Portal and peripheral cortisol levels in obese humans. Diabetologia DOI 10.1007/s00125-004-1389-y
3. Seckl JR, Walker BR (2001) 11β-Hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371-1376
4. Masuzaki H, Paterson J, Shinyama H et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
5. Masuzaki H, Yamamoto H, Kenyon CJ et al. (2003) Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90
6. Kotelevtsev YV, Holmes MC, Burchell A et al. (1997) 11β- Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity and stress. Proc Natl Acad Sci USA 94:14924-14929
7. Morton NM, Holmes MC, Fievet C et al. (2001) Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300
8. Morton NM, Paterson JM, Masuzaki H et al. (2004) Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxy steroid dehydrogenase type 1 deficient mice. Diabetes 53:931-938
9. Alberts P, Engblom L, Edling N et al. (2002) Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45:1528-1532
10. Alberts P, Nilsson C, Selen G et al. (2003) Selective inhibition of 11β-hydroxy steroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycaemic mice strains. Endocrinology 144:4755-4762
11. Livingstone DEW, Jones GC, Smith K, Andrew R, Kenyon CJ, Walker BR (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560-563
12. Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CRW (1992) Mineralocorticoid excess and inhibition of 11β-hydroxy steroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) 27:483-492
13. Katz JR, Mohamed-Ali V, Wood PJ, Yudkin JS, Coppack SW (1999) An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol 50:63-68
14. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW (1995) Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 80:3155-3159
15. Andrews RC, Rooyackers O, Walker BR (2003) Effects of the 11beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 88:285-291
16. Stewart PM, Boulton A, Kumar S, Clark PMS, Shackleton CHL (1999) Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84:1022-1027
17. Rask E, Olsson T, Soderberg S et al. (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418-1421
18. Rask E, Walker BR, Soderberg S et al. (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women; increased adipose 11b-Hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87:3330-3336
19. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi M-C, Grino M (2002) Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 87:2701-2705
20. Wake DJ, Rask E, Livingstone DEW, Soderberg S, Olsson T, Walker BR (2003) Local and systemic impact of transcriptional upregulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 88:2983-2988
21. Lindsay RS, Tataranni A, Permana P, Livingstone DEW, Wake DJ, Walker BR (2003) Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and mRNA levels are associated with adiposity and insulinaemia in Pima Indians and Caucasians. J Clin Endocrinol Metab 88:2738-2744
22. Westerbacka J, Yki-Jarvinen H, Vehkavaara S et al. (2003) Body fat distribution and cortisol metabolism in healthy men: enhanced 5β-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J Clin Endocrinol Metab 88:4924-4931
23. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM (2002) Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 87:5630-5635
24. Bujalska IJ, Walker EA, Hewison M, Stewart PM (2002) A switch in dehydrogenase to reductase activity of 11beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab 87:1205-1210
25. Draper N, Walker EA, Bujalska IJ et al. (2003) Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34:434-439
26. Andrew R, Smith K, Jones GC, Walker BR (2002) Use of multideuterated cortisol to distinguish activities of 11β-hydroxysteroid dehydrogenases in vivo in man. J Clin Endocrinol Metab 87:277-285
27. Walker BR, Seckl JR (2004) 11β-Hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease. Expert Opin Ther Targets 7:771-783